Children @-@ months ( N = @ ) and @-@ months ( N = @ ) of age received vaccine formulations containing either @ g antigen with half the standard dose of MF@ or @ g antigen with a standard dose of MF@ , or a nonadjuvanted formulation containing @ g antigen ( children @-@ months only ) .